Why Ocugen, Inc. (OCGN) stock is popping high today?
Shares of Ocugen, Inc. (OCGN) stock were popping high today on May 7, 2021, ahead of today’s earnings report.OCGN stock price saw a surge of 7.83% to reach $10.33 a share at the time of this writing. OCGN stock was down for the past three days and dropped 12.19% at the previous closing. Let’s discuss […]
What Raised The OCGN Stock Higher In After-Hours Session?
In after-market trading hours on Wednesday, Ocugen Inc. (NASDAQ: OCGN) increased 7.85% in value to $7.01. A price range of $5.83 to $6.76 created volatility in Ocugen stock price during the last trading session. A total of 126.63 million shares of OCGN stock were traded, which is above the daily average of 65.13 million shares […]
What’s Driving Ocugen (OCGN) Stock Higher Pre-Market Today?
The drugmaker Ocugen Inc (OCGN) has been surging nearly 4% at the start of the premarket session today. Before that, the previous session on Friday also came to be impressive for the stock as it closed with a rise of 36.87% to $10.95. Today’s premarket surged could be attributed to news surfaced from the Asian […]
Is that why Ocugen, Inc (OCGN) spiked in the premarket session?
Ocugen, Inc (OCGN)stock surged dramatically 120.77% in the premarket today, despite no news or press releases from the biotechgiant. So what do you need to know? And why is OCGNstock trending higher today? Get the hottest stocks to trade every day before the market opens 100% free. Click here now. The only news affecting OCGN […]
Here how Ocugen, Inc. (OCGN), shares jumped in the After hours
Ocugen, Inc. (NASDAQ: OCGN), shares spiked more than 70% to $1.37 in the After-hours Session after the company announced that on December 23, 2020, at 11:00 a.m. Eastern Time its 2020 Annual Meeting of Stockholders will convene and will adjourn solely concerning its Definitive Proxy Statement filed with the Securities and Exchange Commission on October […]
Why Ocugen, Inc. (NASDAQ: OCGN) share price is going above the radar
Ocugen, Inc. (NASDAQ: OCGN), shares jumped 16.96% to $0.34 in the premarket session after, a biopharmaceutical firm focusing on the exploration, development, and commercialization of innovative therapies for the treatment of blindness diseases, recently confirmed that it would delay its 2020 Annual Meeting of Stockholders to December 23, 2020, to allow more time for its […]
